文献速递脑血管病外科神经重症

目标温度管理治疗高级别动脉瘤性蛛网膜下腔出血:一项初步研究

Targeted Temperature Management for Poor Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
PubMed 文献 · World Neurosurg · 2024-01-17

单盲非随机对照试验纳入60例Hunt-Hess IV~V级动脉瘤性蛛网膜下腔出血患者,按1:1分为目标温度管理组和对照组。目标温度管理组3个月良好预后(改良Rankin量表评分0~3分)比例显著高于对照组(46.7% vs 20.0%,P=0.028),校正多因素logistic回归显示目标温度管理降低3个月不良预后(OR=0.20,95%CI 0.05-0.77,P=0.019)。

要点

  • 目标温度管理组3个月良好预后46.7%,对照组20.0%,差异有统计学意义(P=0.028)。
  • 校正多因素logistic回归显示目标温度管理降低3个月不良预后(OR=0.20,95%CI 0.05-0.77)。
  • 作者认为需多中心大样本随机对照研究证实上述观察结果。

核心结论

  • 本研究显示目标温度管理对高级别动脉瘤性蛛网膜下腔出血患者有效且安全,实施目标温度管理改善了神经功能结局。

研究设计与样本

  • 单盲、非随机对照试验,纳入高级别动脉瘤性蛛网膜下腔出血(Hunt-Hess IV~V级)患者60例,按1:1分为目标温度管理组(30例)和标准治疗对照组(30例)。

主要发现

  • 3个月良好预后(改良Rankin量表评分0~3分)目标温度管理组14例(46.7%)vs 对照组6例(20.0%),P=0.028。
  • 校正多因素logistic回归分析显示目标温度管理降低入院后3个月不良预后(OR=0.20,95%CI 0.05-0.77,P=0.019)。

关键数值与推荐

  • 目标温度管理方案:入院后立即实施核心体温36°C~37°C的目标温度管理,维持至显微夹闭或血管内栓塞;随后快速诱导至33°C~35°C并维持3~5天;之后缓慢复温至36°C~37°C并至少维持48小时。

临床怎么用

  • 作者认为目标温度管理对高级别动脉瘤性蛛网膜下腔出血患者有效且安全,可改善神经功能结局。
  • 作者指出需多中心、大样本随机对照研究证实上述观察结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We assessed the effectiveness and safety of target temperature management (TTM) in treating patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH). The primary objective was to evaluate the neurological outcome at 3 months. Secondary objectives were to assess mortality, delayed cerebral ischemia, cerebral edema, hydrocephalus, midline shift, and laboratory indicators related to TTM. METHODS: A single-blind, nonrandomized controlled trial was conducted. After admission, patients with poor-grade aSAH (Hunt-Hess scores IV ∼ V) were assigned to a TTM group or a control group in a 1:1 ratio. TTM with core temperatures ranging from 36°C to 37°C was performed immediately and maintained until microclipping or endovascular embolization. Subsequently, rapid induction to 33°C ∼ 35°C was carried out and maintained for 3 to 5 days. Then, the patients underwent slow rewarming to 36°C ∼ 37°C and maintained at that temperature for a minimum of 48 hours. RESULTS: Sixty patients (30 treated with TTM and 30 with standard treatment) were included in the study. At 3 months, a favorable prognosis (modified Rankin scale score 0 to 3) was significantly higher in the TTM group than in the control group (n = 14, 46.7% vs. n = 6, 20.0%, P = 0.028). Adjusted multivariate logistics regression analysis indicated that TTM (odds ratio = 0.20, 95% confidence interval: 0.05-0.77, P = 0.019) reduced the number of unfavorable prognoses 3 months after admission. CONCLUSIONS: This study demonstrated the effectiveness and safety of TTM in patients with poor-grade aSAH, and its implementation improved neurological outcomes. Multicenter randomized controlled studies with a large number of patients are needed to confirm these observations.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Liu Y, Li Y, Han B, et al. Targeted Temperature Management for Poor Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. World Neurosurg. 2024. PMID: 38237800. doi:10.1016/j.wneu.2024.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。